Company Filing History:
Years Active: 2023
Title: Innovative Contributions of Talar Tokatlian in Cancer Treatment
Introduction
Talar Tokatlian is an accomplished inventor based in Agoura Hills, California. He has made significant strides in cancer treatment through his innovative research and patent development, aiming to improve outcomes for patients with mesothelin-positive cancers.
Latest Patents
Talar Tokatlian holds a patent titled "Compositions and methods for treating mesothelin positive cancers." This patent describes immune cells that comprise a first activator receptor specific to mesothelin, as well as a second inhibitory receptor specific to a ligand that may be lost in mesothelin-positive cancer cells. The methods outlined in this patent are focused on creating and utilizing these immune cells to treat cancer effectively.
Career Highlights
Tokatlian is currently associated with A2 Biotherapeutics, Inc., where he contributes to advancing biotherapeutic solutions. His dedication to research and innovation has greatly influenced the field of cancer therapies, particularly for hard-to-treat cancer types.
Collaborations
Throughout his career, Talar has collaborated with esteemed colleagues such as Carl Alexander Kamb and Dora Toledo Warshaviak. Their collective expertise and teamwork enhance the potential for groundbreaking discoveries in cancer treatment.
Conclusion
Talar Tokatlian’s contributions to cancer research exemplify the power of innovation in the medical field. His patent and ongoing work at A2 Biotherapeutics, Inc. represent a significant step forward in the quest to improve cancer therapies, offering hope to many patients facing challenging diagnoses.